Very large scale monoclonal antibody purification: the case for conventional unit operations.
about
Industrialization of mAb production technology: the bioprocessing industry at a crossroadsRecovery and purification process development for monoclonal antibody productionCation-exchange chromatography of monoclonal antibodies: characterisation of a novel stationary phase designed for production-scale purificationA non-chromatographic method for the purification of a bivalently active monoclonal IgG antibody from biological fluidsDevelopment of high-productivity, strong cation-exchange adsorbers for protein capture by graft polymerization from membranes with different pore sizes.Fouling of an anion exchange chromatography operation in a monoclonal antibody process: Visualization and kinetic studiesEmerging antibody products and Nicotiana manufacturing.Cleaning-in-place of immunoaffinity resins monitored by in situ ATR-FTIR spectroscopy.Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A OutbreaksDifferential response in downstream processing of CHO cells grown under mild hypothermic conditions.Antibody-based concepts for multipurpose prevention technologies.Downstream Processing Technologies/Capturing and Final Purification : Opportunities for Innovation, Change, and Improvement. A Review of Downstream Processing Developments in Protein Purification.Sophisticated Cloning, Fermentation, and Purification Technologies for an Enhanced Therapeutic Protein Production: A Review.Allogeneic cell therapy bioprocess economics and optimization: single-use cell expansion technologiesPharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque Model.Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture.Closed-loop optimization of chromatography column sizing strategies in biopharmaceutical manufacture.In-column ATR-FTIR spectroscopy to monitor affinity chromatography purification of monoclonal antibodiesFluorescence based real time monitoring of fouling in process chromatography.New platform for simple and rapid protein-based affinity reactions.Development of a generic transient transfection process at 100 L scaleSecond International Conference on Accelerating Biopharmaceutical Development: March 9-12, 2009, Coronado, CA USA.Antibody purification via affinity membrane chromatography method utilizing nucleotide binding site targeting with a small molecule.Evolving trends in mAb production processes.Integrated flow-through purification for therapeutic monoclonal antibodies processing.
P2860
Q24655304-4651C3E8-D824-4D43-91A5-EC7C552DF7ABQ28288423-961DA26D-C22B-4B6D-B516-5C3F548DD41FQ33608532-532218C5-974B-4B6A-AC07-AD52D9F9DB3FQ33752932-4F175C39-E18D-452E-8D72-9A9E5B2ECF9DQ34486515-6E010879-0A73-4314-AF02-14BFB77631A6Q34618103-4EE8655D-62F8-44EE-805A-7F31C56A1475Q35194874-9766F223-5DD7-41FF-A771-D782DDD1DAA0Q36001508-058C00C5-C139-492B-A734-26665F4F8A64Q36269593-9A43F9E6-B5CB-4BEB-8FD5-DA56E19ACA60Q36754078-61E07D51-6629-4441-AA13-FB5B2B830A78Q37083654-DD311747-8D93-4FE4-92A5-377083440EFFQ37601003-9DD65BB2-0D46-4590-B6C1-23AD8A096955Q38631194-CCE527B3-19E1-47F1-8AFC-568E2821B621Q38654852-CA0B0E67-C784-446E-B431-CDCB70000E9DQ39376650-A232FBF2-3846-466D-B471-7E2A6A6B874AQ40239519-9979A8A6-6A16-4757-BA8C-670720BD825BQ41551902-93A9D85A-8998-4CEC-8A85-22995A03A6DBQ41691779-0D895823-60C7-45B2-BEE4-612ACB2E6E00Q41760788-C7BFF372-203E-4862-9936-F5DD7C0C9847Q41775887-6F008EC0-ABBA-46A6-9D9C-F06C699825A4Q41960548-F74E3A0B-B088-4FE4-AB53-D342ECC11D18Q42273656-BFD6EEE6-1024-464A-9274-D63F91AAF3A3Q43070193-9443589B-4C04-41A5-B4EB-D904E549F1DFQ45926628-C4074F7D-5E29-4E79-A90E-02D3B320F052Q52724995-F587662E-1EAE-4F1A-AC05-455999521487Q52739005-9B83A692-3C87-47CD-B1BB-81180F2C0B9B
P2860
Very large scale monoclonal antibody purification: the case for conventional unit operations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Very large scale monoclonal an ...... conventional unit operations.
@en
type
label
Very large scale monoclonal an ...... conventional unit operations.
@en
prefLabel
Very large scale monoclonal an ...... conventional unit operations.
@en
P356
P1476
Very large scale monoclonal an ...... conventional unit operations.
@en
P2093
Brian Kelley
P304
P356
10.1021/BP070117S
P577
2007-09-22T00:00:00Z